A Clinical Trial of Extended (High) Treatment Dose Antibiotics in Combination With Methenamine Hippurate Compared to the Standard of Care (Either Prophylactic (Low) Dose Antibiotic Treatment or Methenamine Hippurate) in Females With Chronic Urinary Tract Infection

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

192

Participants

Timeline

Start Date

December 31, 2025

Primary Completion Date

August 31, 2027

Study Completion Date

September 30, 2027

Conditions
Chronic Urinary Tract Infection
Interventions
DRUG

Treatment dose antibiotic in combination with methenamine hippurate

"Arm A includes treatment with one of three treatment dose antibiotic options, selected by the treating clinician, in combination with methenamine hippurate. Participants allocated to this arm will receive combination therapy, consisting of one of the following antibiotics:~* Cefalexin (500mg four times daily), or~* Nitrofurantoin (100mg twice daily), or~* Trimethoprim (200mg twice daily) in combination with Methenamine Hippurate (1g twice daily) for 12 weeks."

DRUG

Prophylactic dose antibiotic or methenamine hippurate monotherapy

"Arm B includes treatment with one of four prophylactic dose antibiotics or methenamine hippurate, but not both, selected by the treating clinician. Participants in this arm will receive monotherapy of one of the following:~* Amoxicillin (250mg once daily), or~* Cefalexin (125mg once daily), or~* Nitrofurantoin (50mg once daily), or~* Trimethoprim (100mg once daily), or~* Methenamine Hippurate (1g twice daily) for 12 weeks."

Trial Locations (5)

Unknown

Guy's and St Thomas' NHS Foundation Trust, London

University College London Hospitals NHS Foundation Trust, London

Whittington Health NHS Trust, London

Manchester University NHS Foundation Trust, Manchester

Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne

All Listed Sponsors
lead

University College, London

OTHER